Subtype

Bladder Neoplasm

CI-CAN-00001978Explore in graph →

Non-malignant390 active trials10 approved drugs25 evidence items

NCIt: C2901
MeSH: D001749

Research activity

PubMed record counts

Each count is the number of PubMed records returned by the exact query shown, at the time it was run. Counts are research-activity signals, not quality measures.

Data not yet available

No PubMed query has been run for this entity. Counts require a MeSH-anchored query built from the entity's terminology mappings; the query string is stored with each count so it can be reproduced.

What CancerIndex knows

Literature

Linked publications (145)

Publications linked to this entity or its descendants, newest first, 25 per page. Link method and validation status are shown; 'candidate' links have not been reviewed.

pubmedPublishedShowing 76–100 of 145 publications · bibliographic data as recorded by PubMed; abstracts are not reproduced.

The MAZ-POLD1 Signaling Axis Drives Cisplatin Resistance in Bladder Cancer by Activating DNA Damage Repair.
Biao Zhang, Hong Chang, Cheng Wang et al. · Cancers (Basel) · Sep 7, 2026 · PMID 42738412 · candidate dictionary pubmed
PMDA regulatory update on approval and revision of the precautions for use of anticancer drugs in Japan; sevabertinib for lung cancer, gemcitabine intravesical system and durvalumab for bladder cancer, azacitidine for leukemia, cemiplimab for skin cancer, and ropeginterferon alfa-2b for essential thrombocythemia.
Noriomi Matsumura · Int J Clin Oncol · Sep 6, 2026 · PMID 42701955 · candidate dictionary pubmed
Treatment Selection and Survival In Muscle-Invasive Bladder Cancer: Real-World Data on the Impact of Geriatric-8 Screening.
Gaku Okumura, Shugo Yajima, Erika Ikezoe et al. · J Surg Oncol · Sep 6, 2026 · PMID 42702074 · candidate dictionary pubmed
Comment on "A molecular landscape tracking the progression of non-muscle invasive bladder cancer".
Rakesh Arya, Amit Kumar Mohapatra · World J Urol · Sep 6, 2026 · PMID 42701964 · candidate dictionary pubmed
Perioperative and survival outcomes of synchronous vs. metachronous upper tract urothelial carcinoma among bladder cancer patients treated with radical cystectomy and nephroureterectomy: Results from an International Multicenter Collaborative Study-On behalf of the Young Academic Urology (YAU) Urothelial Working Group.
Roberta Corvino, Giuseppe Basile, Valerio Santarelli et al. · Urol Oncol · Sep 5, 2026 · PMID 42701052 · candidate dictionary pubmed
FOXD1 upregulates DARS2-mediated glycolysis to drive cisplatin resistance in bladder cancer.
Xianyong Li, Mingqiang Su, Jingxian Luo et al. · Urol Oncol · Sep 5, 2026 · PMID 42701051

· candidate dictionary

pubmed

Reply to Francesco Di Bello, Andrea Gallioli, Joan Palou, and Alberto Breda's Letter to the Editor re: Roberto Contieri, Marco Paciotti, Alessandro Uleri et al. Second Transurethral Resection of Bladder Tumor Can Be Safely Omitted in Selected Patients with T1 Non-muscle-invasive Bladder Cancer: Results from the Prospective HuNIRe Trial. Eur Urol Oncol 2026;9:404-12.

Roberto Contieri, Rodolfo Hurle · Eur Urol Oncol · Sep 5, 2026 · PMID 42697826 · candidate dictionary pubmed

m6A-modified circCD2AP suppressed ferroptosis in bladder cancer by upregulating FOXC1 to promote PARK7 transcriptional activity.

Jinrong Wang, Jianfu Yang, Kun Yao et al. · Chin Med J (Engl) · Sep 5, 2026 · PMID 40960159 · candidate dictionary pubmed

[Immune checkpoint inhibition plus Bacillus Calmette-Guerin (BCG) therapy in BCG-naive high-risk non-muscle-invasive bladder cancer: a critical review in the context of current evidence].

Georgios Gakis, Frank Vom Dorp · Urologie · Sep 4, 2026 · PMID 42697960 · candidate dictionary pubmed

Time-dependent effects of BCG plus immune checkpoint inhibitors in BCG-naive high-risk non-muscle-invasive bladder cancer: a reconstructed patient-level analysis.

Shugo Yajima, Soichiro Yoshida, Wei Chen et al. · Int Urol Nephrol · Sep 4, 2026 · PMID 42696081 · candidate dictionary pubmed

Biocompatible HA-PBA/PVA Dual-Network Hydrogel Composite System: A Promising Localized Therapeutic Platform for Bladder Cancer.

Zihao Chen, Jiaxin Li, Hong Hu et al. · ACS Appl Bio Mater · Sep 4, 2026 · PMID 42696047 · candidate dictionary pubmed

2026 Updates to the Diagnosis and Treatment of Non-muscle Invasive Bladder Cancer: AUA/SUO Guideline.

Peter E Clark, Jeffrey Holzbeierlein, Sam S Chang et al. · J Urol · Sep 4, 2026 · PMID 42689553 · candidate dictionary pubmed

Cancer-associated fibroblasts-derived CAV1 promotes epithelial-mesenchymal transition and stemness in bladder cancer through activation of the LIF/STAT3 signaling pathway.

Qi Wang, Dengdian Wang, Haihong Jiang et al. · Transl Oncol · Sep 3, 2026 · PMID 42691512 · candidate dictionary pubmed

Adverse event-related discontinuation of maintenance Bacillus Calmette-Guérin therapy and oncological outcomes in non-muscle-invasive bladder cancer.

Ryota Nakayasu, Akihiro Hamada, Toru Sakatani et al. · Int J Clin Oncol · Sep 2, 2026 · PMID 42687062 · candidate dictionary pubmed

[64Cu]CuCl2 as a Novel Metabolic Marker of Progression and Survival in Muscle-Invasive Bladder Cancer.

Francesco Fiz, Gianluca Bottoni, Monica Boitano et al. · Mol Imaging Biol · Sep 2, 2026 · PMID 42686932 · candidate dictionary pubmed

Low-keV Reconstructions, No Extra Scan: Photon-Counting CT's Case for Bladder Cancer Local Staging.

Markus M Obmann · AJR Am J Roentgenol · Sep 2, 2026 · PMID 42684824 · candidate dictionary pubmed

International Society of Urological Pathology Multidisciplinary Expert Consultation Conference on Evaluation of Treatment Effects in Prostate and Bladder Cancer: Working Group 2: The Urinary Bladder.

Michelle R Downes, Sara E Wobker, Steven C Smith et al. · Am J Surg Pathol · Sep 2, 2026 · PMID 42682094 · candidate dictionary pubmed

Real-World Multicentre Evaluation of GALEAS Bladder for Detecting Bladder Cancer in UK NHS Haematuria Clinics.

Lee Silcock, Robert K Hastings, Samuel Clokie et al. · Eur Urol Oncol · Sep 2, 2026 · PMID 42680595 · candidate dictionary pubmed

Regional Variation in Bladder Cancer Clinical Trial Availability in the US.

Koral U Shah, Salvador Jaime-Casas, Ruchi Agarwal et al. · JAMA Netw Open · Sep 1, 2026 · PMID 42690658 · candidate dictionary pubmed

MMP9 Knockout by CRISPR-Cas9 Reduces Bladder Cancer Malignancy But Does Not Synergize With BCG and Anti-PD-L1 in an Orthotopic Mouse Model.

Juliana Alves de Camargo, Maria Carolina Lee, Milena Monteiro de Souza et al. · IUBMB Life · Sep 1, 2026 · PMID 42706676 · candidate dictionary pubmed

Intravesical mitomycin-C administered immediately before transurethral resection of bladder tumor in non-muscle-invasive bladder cancer: Clinical outcomes and molecular predictors from over 3 years of extended follow-up in a phase II trial.

Hye Won Lee, Geehyun Song, Hyung Ho Lee et al. · Investig Clin Urol · Sep 1, 2026 · PMID 42683856 · candidate dictionary pubmed

Intravesical gemcitabine versus Bacillus Calmette-Guérin (BCG) for intermediate-/high-risk non-muscle-invasive bladder cancer during the BCG shortage: Safety, efficacy, and health-economic context.

Tiago Mestriner Costa, Giovanni Demartino, Luis Gustavo Morato de Toledo et al. · Investig Clin Urol · Sep 1, 2026 · PMID 42683855 · candidate dictionary pubmed

Cathepsin V (CTSV) Shapes the Epigenetic-Immune Landscape of Bladder Cancer and Emerges as a Noninvasive Biomarker.

Wallax Augusto Silva Ferreira, Fabio Albuquerque Marchi, Glauco Akelinghton Freire Vitiello et al. · Int J Urol · Sep 1, 2026 · PMID 42649617 · candidate dictionary pubmed

CircFut8 Suppresses Bladder Cancer by Modulating SRSF9-Dependent Pre-mRNA Splicing.

Weifeng Yang, Lv Yao, Lijun Wan et al. · J Gene Med · Sep 1, 2026 · PMID 42643011 · candidate dictionary pubmed

Rapid normal fibroblast-tumor crosstalk promotes cancer-associated fibroblast-like activation and attenuates mitomycin C cytotoxicity in bladder cancer.

Jinhui Gao, Cindy Xinyu Ji, Ci Ren et al. · J Cell Commun Signal · Sep 1, 2026 · PMID 42639377 · candidate dictionary pubmed